Michel Bouvier, IRIC’s CEO, has been elected Fellow of the Royal Society of Canada

Michel Bouvier, CEO, IRIC, IRICoR

Michel Bouvier, CEO, IRIC, IRICoR

Dr. Michel Bouvier, chief executive officer, principal investigator at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal and full professor at the Department of biochemistry and molecular Medicine, Faculty of Medicine, has been elected Fellow to the Academy of Sciences of the Royal Society of Canada.

The newly elected Fellows have diverse backgrounds and disciplines. They have been elected by their peers in recognition of outstanding scholarly, scientific and artistic achievement. Election to the academies of the Royal Society of Canada is the highest honour a scholar can achieve in the Arts, Humanities and Sciences.

“The RSC warmly welcomes this year’s 90 newly elected Fellows. These outstanding scholars, artists and scientists will be joining the Society due to their outstanding work in the arts, humanities and sciences,” said Graham Bell, President of the Royal Society of Canada. “By promoting and recognizing these leading intellectuals and researchers, the Royal Society of Canada continues to be on the forefront of significant advances for the betterment of Canada and the world.”

Professor Bouvier is a recognized expert in the field of cell signaling. With his team he has made a number of major breakthroughs with regard to G-protein coupled receptors (GPCR), and his work has led to the development of concepts and tools making possible the discovery of more effective drugs with fewer adverse effects. His name appears on the 2014 list of scientists most cited internationally, according to a ranking established by the information firm Thomson Reuters. In addition, he is chief executive officer of IRICoR, IRIC’s research commercialization organization and he holds a Canada Research Chair in Signal Transduction and Molecular Pharmacology.

About the Institute for Research in Immunology and Cancer
An ultra-modern research hub and training centre located in the heart of the Université de Montreal, the Institute for Research in Immunology and Cancer (IRIC) was created in 2003 to shed light on the mechanisms of cancer and discover new, more effective therapies to counter this disease. IRIC operates according to a model that is unique in Canada. Its innovative approach to research has already led to discoveries that will, over the coming years, have a significant impact on the fight against cancer. For more information: www.iric.ca

About the Royal Society of Canada
Founded in 1882, the Royal Society of Canada (RSC) comprises the Academies of Arts, Humanities and Sciences of Canada. Its mission is to recognize scholarly, research and artistic excellence, to advise governments and organizations, and to promote a culture of knowledge and innovation in Canada and with other national academies around the world: www.rsc-src.ca

Source
Manon Pepin
Director, Communications and Media Relations
Institute for Research in Immunology and Cancer | IRIC
Université de Montréal
(514) 343-7283 | manon.pepin@umontreal.ca

© 2008-2020 IRICoR